Literature DB >> 11794177

Locking a leukocyte integrin with statins.

P S Frenette1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11794177     DOI： 10.1056/NEJM200111083451911

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 2.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

3.  Statin-induced Krüppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses.

Authors:  De-xiu Bu; Margarite Tarrio; Nir Grabie; Yuzhi Zhang; Hiroyuki Yamazaki; George Stavrakis; Elena Maganto-Garcia; Zachary Pepper-Cunningham; Petr Jarolim; Masanori Aikawa; Guillermo García-Cardeña; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.

Authors:  Susan M Keating; Kevin R Clark; Lisa D Stefanich; Fred Arellano; Caroline P Edwards; Sarah C Bodary; Steven A Spencer; Thomas R Gadek; James C Marsters; Maureen H Beresini
Journal:  Protein Sci       Date:  2005-12-29       Impact factor: 6.725

5.  Inflammatory markers in a 2-year follow-up of coronary artery disease.

Authors:  Katarzyna Mizia-Stec; Zbigniew Gasior; Barbara Zahorska-Markiewicz; Michał Holecki; Paweł Kumor
Journal:  Heart Vessels       Date:  2006-09-29       Impact factor: 2.037

6.  Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.

Authors:  Dan Li; Yufeng Li; Jessica A Hernandez; Rebecca Patenia; Tae Kon Kim; Jahan Khalili; Mark C Dougherty; Patrick J Hanley; Catherine M Bollard; Krishna V Komanduri; Patrick Hwu; Richard E Champlin; Laszlo G Radvanyi; Jeffrey J Molldrem; Qing Ma
Journal:  J Immunother       Date:  2010 Nov-Dec       Impact factor: 4.456

Review 7.  Regulation of integrin activity and signalling.

Authors:  Carl G Gahmberg; Susanna C Fagerholm; Susanna M Nurmi; Triantafyllos Chavakis; Silvia Marchesan; Mikaela Grönholm
Journal:  Biochim Biophys Acta       Date:  2009-03-14

8.  The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity.

Authors:  Koichi Yuki; Nathan S Astrof; Clay Bracken; Ronnie Yoo; Whitney Silkworth; Sulpicio G Soriano; Motomu Shimaoka
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

Review 9.  Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Expert Opin Investig Drugs       Date:  2008-04       Impact factor: 6.206

10.  Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

Authors:  Yang Wang; Dan Li; Dan Jones; Roland Bassett; George E Sale; Jahan Khalili; Krishna V Komanduri; Daniel R Couriel; Richard E Champlin; Jeffrey J Molldrem; Qing Ma
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.